“一带一路”战略下动物药材保护和利用的伦理思考

An Ethical Ponder on Preservation and Utilization of Zoic Medication under“The Belt and Road Initiative”

随着世界人口老龄化节奏的加快,对老年疾病治疗药物的需求急剧增加,副作用较小、以天然药物为主要成分的中医药日益得到国际社会的认同和接受,但长期以来中药在国际上缺乏合法的药品身份,极大地影响了中医药的海外发展,特别是西方国家对中药中的动物药一直都非常抵制,成为中药走向世界的障碍之一。虽然动物药是传统中医药的重要部分,但动物入药与动物权利诉求有着尖锐的矛盾。如何解决动物药保护和利用、效用和崇高之间的两难困境,本文从伦理学视域分析中西文化在动物入药问题上的认识差异和共识,澄清中医在动物入药问题上的认识和实践,阐明中医对动物药材的合理保护和理智的可持续性的利用。

With the accelerated pace of the world population aging, it has provided great opportunities for the rapid development of traditional Chinese medicine （TCM） with natural medicine as its main component. However, the lack of legal status of TCM has long been a great influence on Chinese medicine. There is a big difference in the degree of recognition of TCM among people along the way. If people are still able to accept herbal medicine, they are very exclusive of zoic medication. Although zoic medication is an important part of TCM, zoic medication and animal rights appeal have a sharp contradiction. The question is how to solve the dilemma between the protection and utilization of zoic medication, utility and lofty. This article analyzed the understanding difference and consensus of zoic medication from the ethics perspective under both Chinese and western culture. It clarified the understanding and practice of zoic medication in TCM. It also illustrated the rational protection and sustainable using of zoic medication in TCM.